Picture of Xvivo Perfusion AB logo

XVIVO — Xvivo Perfusion AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMid CapFalling Star

Brief: Xvivo Perfusion Q3 EBITDA Swings To Loss Of SEK 11.2 Million

Oct 23 (Reuters) - Xvivo Perfusion AB  XVIVO.ST :
    * Q3 NET SALES OF NON-DURABLE GOODS SEK 42.3 MILLION VERSUS
SEK
50.1 MILLION YEAR AGO
    * COVID-19 PANDEMIC CONTINUED TO HAVE AN IMPACT ON SALES
DURING
Q3, BUT TO A LOWER EXTENT THAN IN Q2.
    * Q3 EBITDA LOSS SEK 11.2 MILLION VERSUS PROFIT SEK 9.0
MILLION
YEAR AGO

Source text for Eikon:  ID: 
Further company coverage:  XVIVO.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on Xvivo Perfusion AB

See all news